Delegates Premium Access

GLP-1 receptor agonists and co-agonists for the prevention of atrial fibrillation in overweight or obesity: a meta-analysis of randomized controlled trials

Topic: Rhythm Control, Antiarrhythmic Drugs

Congress Presentation

About the speaker

Doctor Paschalis Karakasis

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)
0 follower

6 more presentations in this session

Association of cognitive impairment with dyslipidemia in patients with atrial fibrillation: preliminary results from a prospective registry

Speaker: Doctor S. Mohanty (Austin, US)

Thumbnail

Change in sleep apnea parameters in patients with atrial fibrillation undergoing pulmonary vein isolation: interim analysis of the AAHIi study

Speaker: Doctor P. Basiukiewicz (Grodzisk Mazowiecki, PL)

Thumbnail

SGLT2 inhibitors and the risk of atrial fibrillation recurrence within one year after radiofrequency ablation

Speaker: Doctor M. Velescu (Cluj Napoca, RO)

Thumbnail

Improvement in the severity of sleep disordered breathing three months after pulmonary vein isolation in patients with persistent atrial fibrillation

Speaker: Assistant Professor Y. Naruse (Hamamatsu, JP)

Thumbnail

Impact of mobile health-detected airflow obstruction on periprocedural symptom severity and quality of life in patients with atrial fibrillation undergoing first-time ablation.

Speaker: Ms K. Ignaczak (Warsaw, PL)

Thumbnail

Access the full session

Risk factor management in atrial fibrillation

Speakers: Doctor P. Karakasis, Doctor S. Mohanty, Doctor P. Basiukiewicz, Doctor M. Velescu, Assistant Professor Y. Naruse...
Thumbnail

About the event

Image

EHRA 2026

12 April - 14 April 2026

Sessions Presentations